Jayant S. Vaidya

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Siddhartha Ghai (talk | contribs) at 17:05, 9 May 2021 (added Category:British writers using HotCat). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Jayant S Vaidya
FRCS
जयंत शरद वैद्य
Born
Goa, India
CitizenshipUnited Kingdom
Alma materGoa Medical College
Tata Memorial Centre
University of Mumbai (MBBS, MS, DNB )
University College London (PhD)
Royal College of Surgeons (FRCS, FRCS (Gen Surgery))
Known forBreast Cancer expert, Targeted intra-operative radiotherapy
Scientific career
FieldsOncology, Surgery
Institutions
Websitewww.ucl.ac.uk/surgery/people/prof-jayant-s-vaidya

Jayant S Vaidya is an British-Indian surgeon-oncologist and clinical academic. He is a professor of surgery and oncology at the University College London, London[1] who, together with Michael Baum and Jeffrey S Tobias, developed "Targeted intra-operative radiotherapy", and coined the TARGIT, acronym. He is the author of two books on breast cancer, one on tobacco eradication, and over 200 academic articles.[2][3]

Early life and education

Vaidya was born in Goa, India, to Dr Sharad Vaidya, a cancer surgeon, and Dr Nirmala Vaidya, who together ran the Vaidya hospital in Panaji, Goa, India.[4]

Vaidya received his medical degree (MBBS) from Goa Medical College, Bombay University. He received his first research grant while in the medical school. He moved to Mumbai in 1989 for his surgical oncology residency training and fellowship at municipal hospitals in Mumbai and the Tata Memorial Cancer Hospital.[5]

He migrated to London, the UK, in the 1990s. In London, he worked as a Surgical registrar in several reputed NHS hospitals in London and as a clinical lecturer and research fellow at the University College London Hospital. Subsequently, he was elected Fellow of the Royal College of Surgeons of Glasgow and completed his Ph.D. from University College London, followed by board certification by the Surgical Royal Colleges of Great Britain and Ireland.[citation needed]

From 2004 to 2008, Prof Vaidya was appointed as the Senior Lecturer at the University of Dundee and the Department of Surgery & Molecular Oncology, Ninewells Hospital, where he led the Targeted intraoperative radiotherapy program and related breast cancer research. In the year 2008, he joined as a chair in the Division of Surgery and Interventional Science, University College London.[6][7]

Career

His father founded the Goa Cancer Society, and went on to establish the Gosalia Memorial Cancer Hospital, Dona Paula, Goa - the first full-fledged cancer hospital in the region at the time.[4][8]

Targeted-intraoperative radiotherapy

During his surgical residency training at Tata Memorial Hospital in Mumbai, Dr Vaidya was troubled by patients having to make several visits to the hospital for 6 weeks postoperative radiotherapy. He was concerned about patients who arrived in Mumbai from far-away regions of India and often had to spend a large amount of money to arrange accommodation in the city apart from covering the treatment costs. Many patients had to opt for mastectomy rather than trying to save healthy tissue, as they could not access radiotherapy.[4][9]

Dr Vaidya had his first insight about targeted-intraoperative radiotherapy during his residency at Tata Memorial Hospital. Vaidya later developed the technique further along with fellow UCL clinical academics Professor Jeffrey S Tobias and Professor Michael Baum, in collaboration with the manufacturers by 1998, and the first patient was treated in July 1998 at the Middlesex Hospital in London.[9]

The TARGIT-IORT technique involves delivering single-dose radiotherapy from inside the body via a small ball-shaped device placed inside the breast immediately after lumpectomy while the patient is still under anaesthesia. The procedure lasts for around 20 to 30 minutes. This replaces the need for extra hospital visits, thereby improving patient safety and well-being.[10]

His work has gained significant traction over the years, with TARGIT being adopted at nearly 250+ centres in over 35 countries.[8] His work has been adopted by NHS and is being widely offered to patients across the UK.[11] The treatment success has also appeared a patient testimonies in major dailies in the UK.[12][13][14][15][16]

Dr Vaidya has appeared in various interviews on international media channels and featured on international dailies in connection with his work on breast cancer treatment.[17][18][19][20]

Personal life

Dr Vaidya currently lives with his wife and two children. His family comes from Keri, Ponda, Goa. The surname "Vaidya" is a Sanskrit word meaning "doctor" or "traditional physician." The family derives this name from practicing medicine for over 300 years. He is the great-grandnephew of Dr Dada Vaidya, a famous 19th century doctor from Goa.[21]

Anti-tobacco education and campaign

Vaidya has been involved in the anti-tobacco movement from an early age with his father, who was a vocal critic of tobacco use. His opinions on tobacco ban have appeared on BBC in the past.[22] He has actively campaigned against the advertising of tobacco in any form in sponsorships of sport, such as cricket. This was when Indian cricket team shirts displayed the Wills logo.[23] He has also authored a book by the name Tobacco Quit India.[24]

Selected works

Articles

  • Vaidya, Jayant S.; Bulsara, Max; Baum, Michael; Wenz, Frederik; Massarut, Samuele; Pigorsch, Steffi; Alvarado, Michael; Douek, Michael; Saunders, Christobel; Flyger, Henrik L.; Eiermann, Wolfgang (2020-08-19). "Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial". BMJ. 370: m2836. doi:10.1136/bmj.m2836. ISSN 1756-1833. PMC 7500441. PMID 32816842.
  • Vaidya JS, Vyas JJ, Chinoy RF, Merchant N, Sharma OP, Mittra I (September 1996). "Multicentricity of breast cancer: whole-organ analysis and clinical implications". Br. J. Cancer. 74 (5): 820–4. doi:10.1038/bjc.1996.442. PMC 2074702. PMID 8795588.
  • Belletti B, Vaidya JS, D'Andrea S, et al. (March 2008). "Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding". Clin. Cancer Res. 14 (5): 1325–32. doi:10.1158/1078-0432.CCR-07-4453. PMID 18316551.
  • Vaidya JS, Baum M, Tobias JS, Morgan S, D'Souza D (June 2002). "The novel technique of delivering targeted intraoperative radiotherapy (Targit) for early breast cancer". Eur J Surg Oncol. 28 (4): 447–54. doi:10.1053/ejso.2002.1275. PMID 12099658.
  • Vaidya, Jayant S (31 October 2013). "IORT for breast cancer – the surgical technique of TARGIT". Retrieved 26 July 2016.

Books

  • Vaidya, Jayant S.; Patkar, Vivek (2016). Fast Facts: Early Breast Cancer. Healthpress Press. ISBN 978-1910797129.
  • Vaidya, Jayant S.; Joseph, David (2014). Fast Facts Breast Cancer. Healthpress Press. ISBN 978-1908541628.

References

  1. ^ "Jayant S Vaidya, MS, DNB, FRCS, PhD". University College London. Retrieved 18 January 2021.{{cite web}}: CS1 maint: url-status (link)
  2. ^ "Google Scholar Citations". Retrieved 2021-01-04.
  3. ^ "Books by Jayant S. Vaidya". Retrieved 2021-01-14.
  4. ^ a b c Aug 27, Lisa Monteiro / TNN /; 2020; Ist, 04:58. "Goan-origin doctor lead author in pioneering breast cancer therapy | Goa News - Times of India". The Times of India. Retrieved 2021-03-01. {{cite web}}: |last2= has numeric name (help)CS1 maint: numeric names: authors list (link)
  5. ^ Dias, Remy (27 June 2010). "Full page description about Jayant S Vaidya, including an interview with Remy Dias". Issuu. Retrieved 2021-03-22.{{cite web}}: CS1 maint: url-status (link)
  6. ^ "My Bibliography - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2021-04-10.
  7. ^ ORCID. "Jayant Vaidya (0000-0003-1760-1278)". orcid.org. Retrieved 2021-04-10.
  8. ^ a b Vaidya, J. S.; Vaidya, U. J.; Baum, M.; Bulsara, M.; Joseph, D.; Tobias, J. S.; TARGIT-IORT Global Collaborators (2021-02-05). "Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) to improve breast cancer treatment – better for patients, better for health care systems". UCL Division of Surgery & Interventional Science: London, UK. (2021). doi:10.14324/000.wp.10121050. Retrieved 2021-03-28. {{cite journal}}: |last7= has generic name (help)
  9. ^ a b "Targeted intraoperative radiotherapy for early breast cancer—new evidence challenges traditional treatment". The BMJ. 2020-08-19. Retrieved 2021-03-28.
  10. ^ Vaidya, Jayant S.; Baum, Michael; Tobias, Jeffrey S.; Morgan, Steven; D'Souza, Derek (2002-06-01). "The novel technique of delivering targeted intraoperative radiotherapy (Targit) for early breast cancer". European Journal of Surgical Oncology. 28 (4): 447–454. doi:10.1053/ejso.2002.1275. ISSN 0748-7983. PMID 12099658.
  11. ^ "UK to adopt Indian-origin expert's breast cancer treatment". Hindustan Times. 2014-07-26. Retrieved 2021-03-28.
  12. ^ "A revolution in breast cancer therapy". The Telegraph. Retrieved 2021-03-28.
  13. ^ Holden, Lucy (2017-03-20). "This magic ball spares breast cancer patients weeks of radiotherapy". Mail Online. Retrieved 2021-04-10.
  14. ^ Lang, Kirsty (2017-01-28). "Radiotherapy or 30 minutes with the new breast cancer blaster?". Mail Online. Retrieved 2021-04-10.
  15. ^ Pilkington, Diana (2013-12-30). "The one-stop breast cancer op that spares women weeks of radiotherapy". Mail Online. Retrieved 2021-04-10.
  16. ^ Jourdan, Thea (2011-04-18). "Breast cancer revolution: Now radiotherapy can be delivered in a single blast". Mail Online. Retrieved 2021-04-10.
  17. ^ "Indian-origin expert leads UK's major breast cancer radiotherapy study". The Economic Times. Retrieved 2021-03-28.
  18. ^ "One-shot radiotherapy 'success against breast cancer'". BBC News. 2010-06-05. Retrieved 2021-03-28.
  19. ^ Beck, Melinda (2015-08-24). "Alternative Way to Treat Early-Stage Breast Cancer With Radiation". Wall Street Journal. ISSN 0099-9660. Retrieved 2021-03-28.
  20. ^ "Just 30-min radiation for breast cancer". Zee News. 2010-06-10. Retrieved 2021-04-10.
  21. ^ "Goan Voice UK: supplement on JayantVaidya". www.goanvoice.org.uk. Retrieved 2021-03-28.
  22. ^ "Smoking age 'should rise to 21'". 2008-01-07. Retrieved 2021-03-28.
  23. ^ "BBC News | South Asia | Indian tobacco ads 'encourage smoking'". news.bbc.co.uk. Retrieved 2021-03-28.
  24. ^ Vaidya, Jayant; Vaidya, Nirmala (2001). Tobacco Quit India. Goa, India: Tobacco Control Advocacy Training Workshop.